Superficial Retinal Intercapillary Oxygen Diffusion and Perfusion Deficit Alterations in Patients With Coronary

Natasa Jeremic1,2, Meltem Esengönül1,3, Azin Zarghami2

  • 1Laboratory for Ophthalmic Image Analysis (OPTIMA), Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Insights

Geometric perfusion deficits (GPDs) detected via retinal imaging show significant association with coronary artery disease (CAD). These GPD metrics, particularly in the parafoveal region, offer a promising non-invasive method for CAD detection and severity assessment.

Area of Science:

  • Ophthalmology
  • Cardiology
  • Medical Imaging

Background:

  • Coronary artery disease (CAD) detection can be improved with non-invasive methods.
  • Retinal imaging offers a potential avenue for early CAD detection.

Purpose of the Study:

  • To investigate the association between geometric perfusion deficits (GPDs) in the retina and coronary artery disease (CAD).
  • To analyze the topographical patterns of GPDs in relation to CAD severity.

Main Methods:

  • Optical coherence tomography angiography (OCTA) images of the superficial capillary plexus were analyzed in patients with and without CAD.
  • Metrics such as GPD density, count, ischemic extent (IE), and top 10 GPD areas (MT10) were extracted.
  • Multivariate mixed-effects models were used to assess the association with the Gensini score (GS) for CAD severity.

Main Results:

  • All analyzed GPD metrics (density, IE, MT10, count) showed significant associations with CAD severity (GS).
  • The parafoveal area exhibited the most significant and consistent changes in GPDs.
  • Significant differences in GPDs were observed between non-CAD and moderate/severe CAD groups, with GPD metrics demonstrating higher predictive ability than conventional OCTA metrics.

Conclusions:

  • Four GPD metrics are significantly associated with CAD, with parafoveal GPDs being the most indicative.
  • Retinal GPD analysis can differentiate between patients with and without CAD.
  • GPDs represent a novel, non-invasive biomarker for CAD detection and assessment.
Abstract